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Rapid normalization of interleukin-8 production after low- hyperlipidemia has been reported to reduce nephrotic
density lipoprotein-apheresis in steroid-resistant nephrotic syn- proteinuria [3]. Recently, we have shown that rapid low-
drome. ering of lipoprotein by low-density lipoprotein apheresisBackground. Low-density lipoprotein apheresis (LDL-A)
(LDL-A) significantly improved NS and renal functiontreatment combined with steroids demonstrated significant im-
[4]. Also, several studies have implicated the potentialprovement of nephrotic proteinuria in steroid- or immunosup-
pressive-resistant patients from focal and segmental glomerulo- pathogenic role of cytokines and chemokines, such as
sclerosis (FGS). The mechanisms of the effect of LDL-A in tumor necrosis factor-a (TNF-a), interleukin (IL)-8,
nephrotic syndrome (NS) are unknown, but a reduction in
monocyte chemoattractant protein-1 (MCP-1), IL-2, andinflammatory cytokines and chemokines secreted from macro-
IL-1, which are released from macrophages activated inphages has been supposed.
Methods. Serum levels of interleukin (IL)-8, tumor necrosis part by hyperlipidemia on the progression of glomerular
factor-a (TNF-a), and monocyte chemoattractant protein-1 sclerotic changes that occur in focal and segmental glo-
(MCP-1) were measured by enzyme-linked immunosorbent merulosclerosis (FGS) [5, 6]. In this study, we studiedassay in 27 patients with NS [13 with FGS and 14 with minimal
the influence of lowering LDL cholesterol by LDL-Achange nephrotic syndrome (MCNS)] before and after LDL-A
on the function of peripheral blood mononuclear cellsand in 13 age-matched, healthy controls. We also selected three
FGS patients who were resistant to steroid therapy for at least (PBMCs). We measured IL-8, TNF-a, and MCP-1 in
one month and who had undergone six LDL-A procedures. the sera and supernatants of PBMCs obtained from NS
The effects of steroids and LDL-A on the production of IL-8,
patients before and after LDL-A was performed. TheTNF-a, and MCP-1 by peripheral blood mononuclear cells
results were compared with those of normal controls and(PBMCs) were also determined in some patients.
Results. In NS, the serum levels of IL-8 and TNF-a, but not nontreated NS patients.
MCP-1, were significantly higher than in healthy controls. After
LDL-A, IL-8 and TNF-a tended to decrease. IL-8 production
by lipopolysaccharide (LPS)-stimulated PBMC, mainly adher- METHODS
ent cells, was significantly reduced in both the steroid-resistant
Serum cytokines and chemokines were examined inFGS group and nontreated NS group compared with controls,
27 nephrotic patients [13 FGS and 14 minimal changebut TNF-a production was reduced in the only FGS group.
After LDL-A, only IL-8 production recovered to the control nephrotic syndrome (MCNS); 13 receiving steroid ther-
group level. apy] and 13 age-matched healthy controls. LDL-A was
Conclusion. Significant amelioration of IL-8 production in- performed 18 times in an additional seven patients with
dependent of any effect of steroids on LPS-stimulated PBMCs
steroid-resistant FGS. Blood samples were obtained be-may reflect a beneficial effect of LDL-A in normalizing the
fore and after LDL-A. In another three patients withfunction of circulating monocytes in steroid-resistant FGS.
FGS, examination of cytokine release from PBMCs be-
fore and after six LDL-A procedures was also per-
formed. Five nephrotic patients [two FGS and threeHyperlipidemia is a factor known to play an important
membranous nephropathy (MN)] not receiving steroidrole in the progression of renal injury and deterioration
therapy were selected as controls to examine the influ-of proteinuria in patients with severe nephrotic syn-
ence of prednisolone. LDL-A was performed using poly-drome (NS) [1, 2]. In these patients, amelioration of
sulfone hollow fibers (Sulflux, Kaneka, Osaka, Japan)
as the plasma separator and a dextran sulfate cellulose
Key words: FGS, nephrotic syndrome, PBMC, TNF-a. column (Liposorba LA-15, Kaneka) as an LDL absor-
bent, processing a total of 3000 ml of plasma during each 1999 by the International Society of Nephrology
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Table 1. Average concentration of interleukin-8 (IL-8),
transforming necrosis factor-a (TNF-a) and monocyte
chemoattractant protein type 1 (MCP-1) in sera from
normal controls and patients
TNF-a MCP-1
N IL-8 ng/ml pg/ml
Normal 7 ND ND 138688.6
FGS 13 3616104.2a 5.160.6 277656.1b
MCNS 14 3296141.0 6.162.9 166670.4b
ND is not detected.
a Data are mean 6 sd.
b Not significant vs. normal controls
apheresis [7]. One 3 106 cells/ml PBMCs were isolated by
density gradient centrifugation from heparinized blood
sample using lymphocytoseparation solution. To sepa-
rate adherent monocytes, PBMCs were incubated for
four hours on a plastic plate, and the nonadherent cells
floating in the medium were separated by transfer to a
new plate after gentle pipetting. A new medium was
poured into the plate with the adherent monocytes. To
all of these cell plates, 1 mg/ml lipopolysaccharide (LPS)
was added, and after incubation for 24, 48, and 72 hours,
supernatants were collected. Quantitations of IL-8 and
TNF-a were performed using the commercially available
enzyme-linked immunosorbent assay (ELISA) kits (Quan-
tikin; R&D Systems, Minneapolis, MN, USA). MCP-1
was quantitated by sandwich ELISA using mononuclear
Fig. 1. Production of interleukin (IL)-8 (A) and tumor necrosisantihuman MCP-1 antibody [8], which was provided by
factor-a (TNF-a; B) by lipopolysaccharide-stimulated PBMCs from
Dr. N. Mukaida, Kanazawa University School of Medi- three focal and segmental glomerulosclerosis (FGS) patients who under-
went six low-density lipoprotein apheresis (LDL-A) procedures.cine. The statistical analysis was performed by the paired
PBMCs were cultured with LPS for 24, 48, and 72 hours. A concentrationand unpaired Student’s t-test and analysis of variance.
of IL-8 and TNF-a in supernatants of peripheral blood mononuclear
P values of less than 5% were used to represent a signifi- cells (PBMCs) from control group ( ) and FGS patients before ( )
and after ( ) LDL-A is shown. *P , 0.05; **P , 0.01; vs. control.cant difference.
RESULTS AND DISCUSSION
In healthy controls, serum IL-8 and TNF-a were not result, at least in part, of the reduction in LDL and other
lipids [9].detected by our ELISA kit, whereas marked elevation of
IL-8 and TNF-a levels were noted in the 27 NS patients The production of these cytokines and chemokines
reflects the activity of monocytes or lymphocytes. The(Table 1). On the other hand, MCP-1 was the same range
as in healthy controls. These findings were consistent release of IL-8 by LPS-stimulated PBMCs was signifi-
cantly suppressed in all NS patients, including those withwith those of Garin et al, who demonstrated high levels
of circulating IL-8 in the nephrotic stage in MCNS pa- steroid-treated FGS and untreated NS. TNF-a produc-
tion by PBMCs was suppressed in only the steroid-tients but undetectable levels in the remission phase [6],
suggesting a potential role of IL-8 in modulating protein- treated FGS patients but not in the untreated NS pa-
tients. MCP-1 production was not suppressed in any NSuria in MCNS. Steroid therapy significantly suppressed
circulating TNF-a (P , 0.05). In contrast, IL-8 concen- patient. The separation of adherent from nonadherent
cells revealed that IL-8 was mainly produced by adherenttration was not influenced by steroid administration. In
comparison to the values before and after each of the monocytes in contrast to TNF-a and MCP-1 whose pro-
duction was not clearly from either cell fraction. AfterLDL-A procedures, serum TNF-a and IL-8 concentra-
tions markedly decreased. Whether this was a result of the LDL-A procedure, only IL-8 production returned
to normal levels (Fig. 1). There was no significant differ-a direct effect on macrophage or a result of increased
removal cannot be determined from these studies. How- ence in TNF-a and MCP-1 secretion from PBMCs be-
tween before and after LDL-A. Investigation of produc-ever, a reduction in the cytokine production could be a
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